Verrica Pharmaceuticals Inc. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
Verrica Pharmaceuticals Inc. (VRCA) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $733.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2020-03-13
- Verrica Pharmaceuticals Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2019 was $733.00K.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month |
|---|---|
| 2019-12-31 | $733.00K 10-K · filed 2020-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |